Earth Science Tech Inc. (OTC: ETST), a biotechnology company focused on nutraceuticals, bioceuticals, and nutritional supplements, recently announced a new provisional patent covering a composition of cannabidiol (“CBD”), alone or as a component of hemp oil, for use in treating or preventing cancer. The move follows its groundbreaking research in partnership with the University of Central Oklahoma.

“I am very delighted to see that our efforts and positive developments with Dr. Wei Chen along with Dr. Feifan Zhou and the University of Central Oklahoma have resulted in the second (2nd) filing of a patent application with the United States Patent and Trademark Office (USPTO) for Hemp Oil Enriched with CBD (Cannabidiol),” said Earth Science Tech Inc. CEO Dr. Harvey Katz. “The filing of this second (2nd) patent application and assignment to ETST is just the beginning of many other great things to come.”

The patent comes shortly after the company filed its first provisional patent back in October 2014. While management didn’t outline many of its plans, in order to maintain confidentiality and protect the idea as its being developed, the patent is also likely related to the treatment and/or prevention of cancer following its work with the University of Central Oklahoma through a Sponsored Research Agreement in conjunction with Dr. Katz.

“As previously stated ETST looks to build a strong intellectual property portfolio and it is doing just that. ETST now has 2 provisional patents and inventions with its CBD Rich Hemp Oil (patent Serial No. 62102538 and patent Serial No. 62061577),” added Dr. Katz. “We look forward to continuing to grow ETST in order to help consumers Worldwide with their overall Health and Wellness through cutting edge Nutraceuticals and Dietary supplements.”

With the second new provisional patent, the company has a total of ten new claims within its intellectual property portfolio. Management also continues to work with the University of Central Oklahoma to investigate the effects of CBDs on immune cells using the company’s CBD Rich Hemp Oil, which is being provided via a new relationship with an international supplier.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: